ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
September 17, 2024 06:30 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy
September 04, 2024 07:46 ET
|
ANEW MEDICAL, INC.
Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
August 26, 2024 05:00 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
August 21, 2024 05:00 ET
|
ANEW MEDICAL, INC.
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke...
ANEW MEDICAL, INC. Appoints New CFO
August 19, 2024 05:00 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Appoints New CFO
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
August 15, 2024 05:00 ET
|
ANEW MEDICAL, INC.
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S. -based biotechnology company focused on developing cell and gene-based treatments for...
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
August 09, 2024 05:00 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS
August 08, 2024 05:00 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS
ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
July 09, 2024 05:30 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene
June 27, 2024 05:00 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene